Ohm - wholeheartedly agree with you. Cytodyn has literally just been given the solution key to an exam that they are going to be preparing themselves. No more DSMC, no more unknowns, no more guesswork, fast enrollment, easy analysis.

It’s literally now just a matter of short time for it to play out. The stock should in theory price in the cost of running the company and trial until that time along with the very high probability of success. What is near certain inevitability worth to the market?

Guess we will see. Anyone who thinks the market is inefficient and believes the price doesn’t reflect that reality, will most certainly buy.

Oh, and just make sure you buy before someone potentially comes out of left field and decides to approve this outside the US.

I am actually more calm and sure about what I own and how it will now play out than ever before. This stock just got massively derisked.